TAPESTRY PHARMACEUTICALS INC has a total of 59 patent applications. It decreased the IP activity by 66.0%. Its first patent ever was published in 1999. It filed its patents most often in United States, EPO (European Patent Office) and Australia. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are SUZHOU SINOVENT PHARMA CO LTD, SUZHOU SINOVENT PHARMACEUTICALS CO LTD and CHONG KUN DANG PHARM CORP.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 22 | |
#2 | EPO (European Patent Office) | 8 | |
#3 | Australia | 5 | |
#4 | Canada | 5 | |
#5 | WIPO (World Intellectual Property Organization) | 5 | |
#6 | Japan | 4 | |
#7 | China | 3 | |
#8 | Mexico | 3 | |
#9 | Argentina | 1 | |
#10 | Israel | 1 | |
#11 | Republic of Korea | 1 | |
#12 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Environmental technology | |
#4 | Biotechnology |
# | Name | Total Patents |
---|---|---|
#1 | Mcchesney James D | 48 |
#2 | Ferrara James | 18 |
#3 | Henri John T | 14 |
#4 | Kurman Michael | 11 |
#5 | Marshall John | 11 |
#6 | Zygmut Jan | 11 |
#7 | Venkataraman Sylesh | 10 |
#8 | Stemphoski Aaron Michael | 9 |
#9 | Walker Donald G | 9 |
#10 | Foster Jonathan E | 9 |
Publication | Filing date | Title |
---|---|---|
WO2008121476A1 | Biologically active taxane analogs and methods of treatment by oral administration | |
WO2008109360A1 | Taxane analogs for the treatment of brain cancer | |
AU2007245085A1 | A convergent process for the synthesis of taxane derivatives | |
MX2008008119A | Processes for taxane derivatives and intermediates useful therein. | |
KR20080030564A | Molecular constructs suitable for targeted conjugates | |
CN101370798A | Novel compounds for forming taxone, method and use thereof | |
US2006281807A1 | Quassinoid compositions for the treatment of cancer and other proliferative diseases | |
EP1810968A2 | 9, 10-a, a-OH-taxane analogs and methods for production thereof | |
CA2539975A1 | 9,10-.alpha.,.alpha.-oh-taxane analogs and methods for production thereof |